Zimmer Biomet launched an educational campaign in an effort to encourage people with chronic joint pain to make informed decisions about joint surgery during COVID-19.
Orthopedic companies are anxious to get patients back into the operating room for hip and knee replacements. Zimmer Biomet recently launched an educational campaign in an effort to guide people with chronic joint pain on navigating joint surgery during COVID-19.
The company said that the multimedia campaign, Don’t Let Pain Gain on You, is informed by the results of a new U.S. survey that reveals nearly half (48%) of joint surgery candidates have postponed treatment due to fears stemming from the COVID-19 pandemic.
“We understand why the pandemic has created uncertainty around elective procedures like joint replacement surgery, but we also know that for some people coping with chronic debilitating joint pain, postponing a necessary procedure could have a significant impact on quality of life and continue to cause life-altering pain and loss of mobility,” said Ivan Tornos, group president for global businesses and the Americas at Zimmer Biomet. “With this new campaign, we look to encourage people to have a proactive conversation with their doctor about joint replacement surgery and get the support and care they need to address their pain, safely and with confidence.”
The U.S. survey of 1,200 joint surgery patients, candidates, and caregivers, conducted in August and September 2020 by Wakefield Research on behalf of Zimmer Biomet, revealed that the vast majority (82%) of people who did undergo joint surgery during the pandemic said that they felt safe doing so, and 64% said they did not feel at risk for contracting a virus, such as COVID-19, at the site of their surgery.
Image Credit: The New York Times